Company / Return on Assets (ROA)
United Therapeutics Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
16.9%
FY2025
5-year range
9.2% / 16.9%
FY2021-FY2025
Trend
+4.4%
vs FY2024
Sector context
#16 of 213
Health Care
What the data says
Among 213 Health Care companies, United Therapeutics is in the top 8% for return on assets (roa). Return on Assets (ROA) has increased for 5 consecutive years, from -2.7% in FY2019 to 16.9% in FY2025.
Based on SEC 10-K filings.
16.9% in FY2025 with a 3-year CAGR of +4.9%. Top quartile in the Health Care sector.
Improved from 13.7% to 16.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +4.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 8% in Health CareTop 8% of 213This company 16.9% Sector average -24.1%
▼
+170.2% above sector average
Key checks
Key Insights
- United Therapeutics's return on assets (roa) has grown for 4 consecutive years.
- In FY2025, return on assets (roa) increased 4.4% year-over-year.
- Currently 41.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 16.9% | +4.4% |
| FY2024 | 16.2% | +18.1% |
| FY2023 | 13.7% | +14.2% |
| FY2022 | 12.0% | +30.8% |
| FY2021 | 9.2% | - |
| FY2020 | - | - |
| FY2019 | -2.7% | -115.4% |
| FY2018 | 17.3% | -23.5% |
| FY2017 | 22.6% | -26.3% |
| FY2016 | 30.7% | +2.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026